Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
2,631 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Bleeding events in people with hemophilia B on prophylactic factor IX treatment: a systematic review and meta-analysis.
Lindsley K, Nevo A, Colavecchia C, Wilcox LJ, Patel P, Estevez C, Khanji C, Uyei J, Pipe SW, Young G. · Res Pract Thromb Haemost · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- PD-1/ PD-l1 Inhibitors and Stereotactic Radiosurgery for Brain Metastases: a systematic review and meta-analysis.
Alswaiti Y, Shahwan G, Alhayek B, Absi S, Alzyoud A, Kanaan D, Nawar B, Whdan MM, Gutierrez-Valencia E, Erjan A. · Clin Exp Metastasis · 2026 · cited 0 timesmeta-analysis, systematic review
- Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.
Olasupo OO, Noronha N, Lowe MS, Ansel D, Bhatt M, Matino D. · Cochrane Database Syst Rev · 2026 · cited 2 timesmeta-analysis, systematic review
- Gene therapy in the treatment of hemophilia A: a systematic review and meta-analysis.
Silva Mendes AC, Camelo RM, Clicia Moura Henriques L, Lamounier de Almeida D, Alves de Jesus VE, Muniz Junior RL, Álvares-Teodoro J. · Expert Rev Hematol · 2026 · cited 2 timesmeta-analysis, systematic review
- Denecimig (Mim8) prophylaxis over 52 weeks in adolescents and adults with hemophilia A: FRONTIER2 extension study.
Jiménez-Yuste V, Abraham A, Tomuleasa C, Alzahrani H, van Vulpen L, Yang R, Obaji S, Ahuja S, Susen S, Lentz SR, Høgh AR, Rakhmatullin I, Hermans C. · Res Pract Thromb Haemost · 2026 · cited 1 timesOpen accessclinical trial, phase iii, multicenter study
- Efficacy and safety of platelet-rich plasma injection for hemophilic chronic synovitis and arthropathy: a systematic review and meta-analysis.
Yin S, Lu Y, He Q, Bi H, Zhou Z. · Ann Hematol · 2026 · cited 1 timesOpen accessmeta-analysis, systematic review
- Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study.
Young G, Angchaisuksiri P, Apte S, Frandsen RB, Chan AKC, Chowdary P, Eichler H, Lyu CJ, Martinez Garcia MF, Matsushita T, Trakymienė SŠ, Tran H, Trinchero A, Windyga J, Astermark J. · Blood Adv · 2026 · cited 0 timesOpen accessclinical trial, phase iii, multicenter study
- Laser interstitial thermal therapy (LITT) for brain metastases: a systematic review and pooled analysis of Efficacy/Safety and the role of combination treatments.
Mizutani Y, Hori YS, Kattaa AH, Harary PM, Lam FC, Kalra N, Zagzoog N, Tayag A, Ustrzynski L, Emrich SC, Park DJ, Chang SD. · J Neurooncol · 2026 · cited 0 timesmeta-analysis, systematic review
- Prior Decompensation Identifies Patients at High Mortality Risk Despite Standard Therapy After Variceal Hemorrhage: An Individual Patient Data Meta-Analysis.
Turco L, La Mura V, Olivas P, Rudler M, Villanueva C, Hernandez-Gea V, Han G, Chirapongsathorn S, Shalimar, Bucsics T, Palazon JM, Reiberger T, Thabut D, Garcia-Guix M, Luo X, Sharma S, Agarwal S, Bosch J, Garcia-Pagan JC, D'Amico G, Garcia-Tsao G. · Clin Gastroenterol Hepatol · 2026 · cited 0 timesmeta-analysis, systematic review
- Oral Clues to Undiagnosed Congenital Hemophilia: A Systematic Review of Case Reports.
Badagabettu S, Kumar M. · Spec Care Dentist · 2026 · cited 0 timessystematic review
- TNF‑α Gene Polymorphisms as Determinants of Alloantibody Emergence in Hemophilia: A Systematic Review and Meta-Analysis.
Bezerra AFDC, de Sousa NAAC, Rezende SM, Souza RP. · Haemophilia · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Bridging the Gap: A Systematic Review of Modern Hemophilia Therapies and Global Inequities in Clinical Trial Participation.
Afifah NN, Permatasari LI, Latarissa IR, Wijaya I. · Haemophilia · 2026 · cited 0 timessystematic review
- Systemic and intracranial activity of antibody-drug conjugates in patients with non-small cell lung cancer and brain metastases: A systematic review and meta-analysis.
Zhou S, Tan J, Patel V, Kishi N, Akhtar K, Benjamin S, Homsi J, Tsao CK. · Lung Cancer · 2026 · cited 1 timesmeta-analysis, research support, non-u.s. gov't
- Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study.
Mahlangu J, Boban A, Bruzelius M, Castaman G, Hampton K, Knoebl P, Lebreton A, Linari S, López-Jaime FJ, Martins Mazini Tavares C, Nekkal MS, Nogami K, Rhode Høgh Nielsen A, Shapiro A, d'Oiron R. · Blood Adv · 2026 · cited 3 timesOpen accessclinical trial, phase iii, multicenter study
- Factor IX Padua AAV gene therapy in adolescents with hemophilia B: a phase 1 trial.
Xue F, Zhang A, Ju M, Wu X, Xu B, Pei X, Wang Y, Liu W, Liu A, Jiang W, Dai X, Chen Y, Liu X, Fu R, Sun T, Gu W, Zheng J, Du Z, Yang C, Xiao X, Yang R, Hu Q, Zhang L. · Nat Med · 2026 · cited 0 timesmulticenter study, clinical trial, phase i
- The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis.
da Conceição Bezerra AF, Batista-Rodrigues YK, Rezende SM, Souza RP. · Thromb Res · 2025 · cited 0 timesmeta-analysis, systematic review
- Denecimig (Mim8) prophylaxis once every 2 weeks for hemophilia A with or without inhibitors: 26-week results from FRONTIER4.
Matsushita T, Banchev A, Bovet J, Chowdary P, García Fernández LM, Jiménez-Yuste V, Kavakli K, Kremer Hovinga JA, Windyga J, Young G. · Blood Adv · 2026 · cited 3 timesOpen accessclinical trial, phase iii, clinical trial, phase ii
- Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.
Mancuso ME, Chan AKC, Shanmukhaiah C, Lyu CJ, Zdziarska J, Mahlangu J, van Vulpen LFD, Chowdary P, Yang R, Lentz SR, Matsushita T, Clausen WHO, Rakhmatullin I, Oldenburg J, FRONTIER2 Investigators. · N Engl J Med · 2026 · cited 3 timesclinical trial, phase iii, comparative study
- Comparative Efficacy and Safety of Non-Clotting Factor Prophylaxis Versus. on-Demand Therapy in Hemophilia: A Meta-Analysis of Randomized Controlled Trials.
Ishaque R, Talpur AS, Memon H, Ahuja L, Reya F, Ikram A, Siddiqui MA, Ali M, Danish H, Khan MRA, El Joujou R, Janjua H, Janjua H, Reddy A, Rayamajhi S. · Clin Appl Thromb Hemost · 2026 · cited 1 timesOpen accessmeta-analysis, comparative study
- Efficacy of radiosynoviorthesis on clinical outcomes in persons with haemophilia. A systematic review and meta-analysis.
Schmidt A, Wiese J, Tomschi F, Boddenberg-Pätzold B, Strauss AC, Hilberg T. · Thromb Res · 2026 · cited 0 timesmeta-analysis, systematic review
- Denecimig (Mim8) prophylaxis in children with hemophilia A with or without factor VIII inhibitors.
Kenet G, Berrueco R, Fijnvandraat K, Kjöllerström P, Luciani M, Mahlangu J, Radhakrishnan N, Wu R, Páramo Florencio A, Thaung Zaw JJ, Carcao M. · Res Pract Thromb Haemost · 2026 · cited 0 timesclinical trial, phase iii, multicenter study
- F8 Genotype and Immune Tolerance Induction Outcome in People with Hemophilia A and Inhibitors: A Systematic Review and Meta-Analysis.
Barbosa JO, Barbosa IO, Souza RP, Zucheratto LW, Gouw SC, Rezende SM, Camelo RM. · Thromb Haemost · 2026 · cited 0 timesclinical trial
- Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A.
Sidonio RF, Mullins ES, Peyvandi F, Chan AKC, Stasyshyn O, Yeoh SL, Sosothikul D, Antmen AB, El-Kamary SS, Gu J, Tangada S. · Res Pract Thromb Haemost · 2026 · cited 1 timesclinical trial, phase iii, multicenter study
- Prospective collection of bleeding rate and factor usage in participants with hemophilia A and B in a noninvestigational product study.
Kavakli K, Frenzel L, Antmen AB, Alzahrani H, Matino D, Leavitt AD, Ozelo MC, Astermark J, Park YS, Klamroth R, Cuker A, Konkle BA, McKay J, Agathon D, Tseng LJ, Resa MLA, Healy J, Wilcox LJ, Plonski F. · Res Pract Thromb Haemost · 2026 · cited 0 timesOpen accessclinical trial, multicenter study
- Safety and efficacy of marstacimab in patients with hemophilia A and B: a systematic review and meta-analysis.
Mokresh ME, Alomari O, Mokresh S, Caliskan CS, Ilter MK. · Expert Rev Hematol · 2025 · cited 1 timesmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.